Loading...
News
    Shows

      Study suggests extending tamoxifen treatment

      |A new breast cancer study shows women who took tamoxifen for 10 years, instead of the recommended five, were 25 percent less likely to have a recurrence of the disease and 29 percent less likely to die. Elaine Quijano reports.

      Related Videos

      You Might Like

      Comments